Phosphatidylinositol 3,4-bisphosphate: Out of the shadows and into the spotlight.

AKT PI(3,4)P(2) Phosphoinositides Signal transduction endocytosis mTOR migration

Journal

Current opinion in cell biology
ISSN: 1879-0410
Titre abrégé: Curr Opin Cell Biol
Pays: England
ID NLM: 8913428

Informations de publication

Date de publication:
21 May 2024
Historique:
received: 05 12 2023
revised: 15 04 2024
accepted: 01 05 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 22 5 2024
Statut: aheadofprint

Résumé

Phosphoinositide 3-kinases regulate many cellular functions, including migration, growth, proliferation, and cell survival. Early studies equated the inhibition of Class I PI3Ks with loss of; phosphatidylinositol 3,4,5-trisphosphate (PIP3), but over time, it was realised that these; treatments also depleted phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2). In recent years, the; use of better tools and an improved understanding of its metabolism have allowed for the; identification of specific roles of PI(3,4)P2. This includes the production of PI(3,4)P2 and the; activation of its effector Akt2 in response to growth factor signalling. In contrast, a lysosomal pool of PI(3,4)P2 is a negative regulator of mTORC1 during growth factor deprivation. A growing body of literature also demonstrates that PI(3,4)P2 controls many dynamic plasmalemmal processes. The significance of PI(3,4)P

Identifiants

pubmed: 38776601
pii: S0955-0674(24)00051-6
doi: 10.1016/j.ceb.2024.102372
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102372

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jayatee Ray (J)

Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

David G Sapp (DG)

Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Gregory D Fairn (GD)

Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: gfairn@dal.ca.

Classifications MeSH